Laser-Assisted Drug Delivery Is Effective in Alopecia but Lacks Comparison With Existing Treatments
April 10th 2024Studies show that laser-assisted drug delivery (LADD) improves hair growth in patients with alopecia. However, researchers are still looking at the best ways to compare LADD's effectiveness against other methods like microneedling.
Read More
Neoadjuvant Chemoimmunotherapy Shows Superiority in Non–Small Cell Lung Cancer Treatment
April 9th 2024The study compared the adverse events and surgical, pathological, and efficacy outcomes associated with neoadjuvant chemoimmunotherapy vs chemotherapy, particularly focusing on patients with PD-L1 levels less than 1%.
Read More
Nirogacestat Linked With Improved Functional Status in Patients With Desmoid Tumors
April 9th 2024Results presented at the National Community Oncology Dispensing Association International Spring Forum describe meaningful improvements in functioning among patients who received the oral gamma secretase inhibitor to treat progressing desmoid tumors.
Read More
Mammography Use Linked to Social Determinants, Revealing Need to Bridge Gaps With Community Support
April 9th 2024While mammograms are crucial for early detection of breast cancer and can save lives, social determinants of health and health-related social needs create barriers to access, especially for those with financial hardship, lack of transportation, or social isolation.
Read More
Ultraprocessed Foods, Ice Cream Associated With Mortality in CRC Survivors
April 9th 2024Among patients who have survived colorectal cancer (CRC), there was an association between increased mortality due to CRC or cardiovascular disease and higher intake of ice cream and ultraprocessed foods.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
In AML, CAR T-Cell Therapy Has Higher CR Rate After Transplant
April 8th 2024In this investigation, investigators sought insights into the safety and efficacy of chimeric antigen receptor (CAR) T-cell therapy in acute myeloid leukemia (AML), with a particular focus on how various patient subgroups fared for complete remission (CR).
Read More
Health Equity and Access Weekly Roundup: April 8, 2024
April 8th 2024The Center on Health Equity and Access covered the burden faced by caregivers, transgender health care, pre-exposure prophylaxis uptake, disparities in postpartum mental health care, and cost-related medication nonadherence among patients with chronic obstructive pulmonary disease.
Read More
There is discrepancy between the FDA’s accelerated approval decisions and clinical benefits in cancer treatments; former President Donald Trump’s video statement avoids a clear stance on national abortion legislation; 40% of therapists say they will increase their fees this year.
Read More
Dr Raajit Rampal Discusses Disease Modification and Emerging Therapies in Polycythemia Vera
April 7th 2024Raajit Rampal, MD, PhD, of Memorial Sloan Kettering Cancer Center, discusses the potential of a disease-modifying therapy in polycythemia vera, treating high-risk vs low-risk patients, and emerging therapies in the pipeline.
Watch
FDA Approves Cilta-Cel for Earlier Treatment of RRMM
April 6th 2024Most recently, the FDA’s Oncologic Drugs Advisory Committee unanimously voted to recommend ciltacabtagene autoleucel (Carvykti; Johnson & Johnson) in patients who have received at least 1 line of treatment for relapsed/refractory multiple myeloma (RRMM).
Read More
Breast Cancer Risk Not Linked to SSRIs; Prolactin Levels Warrant Careful Prescribing
April 6th 2024A recent study found a minor link between prolactin levels and the risk of developing estrogen receptor (ER)-positive or ER-negative breast cancers. However, there was no association found between the use of selective serotonin reuptake inhibitors (SSRIs) and breast cancer risk.
Read More
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
Kathy Oubre on Navigating the Aftermath of the Change Healthcare Cyberattack
April 5th 2024Kathy Oubre, MS, CEO of Pontchartrain Cancer Center, is 1 of 6 cochairs for the 2024 Community Oncology Conference, and here she discusses how meeting content has incorporated ongoing coverage of the extremely disruptive cyberattack and how there is still so much work to be done.
Watch